• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,299.21
  • 0.21 %
  • $78.58
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Cerevel Therapeutics Holdings, Inc. (CERE) Insider Traders

Cerevel Therapeutics Holdings, Inc. (CERE) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price
Day's range
$44.96
Day's range
$44.99
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    0
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    8
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $0
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $16.95 M

Cerevel Therapeutics Holdings, Inc. Insider Transactions

Cerevel Therapeutics Holdings, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
COLES N ANTHONY

Director

Sell 50,000 @ $40.61 $2.03 M 15,638 06/03/2024 06/05/2024
COLES N ANTHONY

Director

Sell 50,000 @ $42.10 $2.11 M 15,638 05/10/2024 05/14/2024
COLES N ANTHONY

Director

Sell 50,000 @ $42.33 $2.12 M 15,638 04/01/2024 04/03/2024
COLES N ANTHONY

Director

Sell 50,000 @ $41.01 $2.05 M 15,638 03/04/2024 03/06/2024
COLES N ANTHONY

Director

Sell 50,000 @ $41.16 $2.06 M 15,638 02/29/2024 03/04/2024
Renger John

Chief Scientific Officer

Sell 2,161 @ $41.54 $89,777 6,370 02/07/2024 02/08/2024
COLES N ANTHONY

Director

Sell 2,506 @ $41.54 $104,110 15,638 02/07/2024 02/08/2024
COLES N ANTHONY

Director

Sell 50,000 @ $42.24 $2.11 M 2,704 01/02/2024 01/04/2024
Sanchez Ramiro

Chief Medical Officer

Sell 10,000 @ $42.47 $424,700 14,673 12/26/2023 12/28/2023
DiPietro Kenneth

Chief Human Resources Officer

Sell 8,000 @ $41.45 $331,608 24,663 12/22/2023 12/27/2023
Bodenrader Mark

See Remarks

Sell 7,889 @ $41.42 $326,788 17,724 12/20/2023 12/21/2023
DiPietro Kenneth

Chief Human Resources Officer

Sell 6,256 @ $41.42 $259,144 24,663 12/20/2023 12/21/2023
Akamine Scott

Chief Legal Officer

Sell 7,072 @ $41.42 $292,945 7,237 12/20/2023 12/21/2023
Sanchez Ramiro

Chief Medical Officer

Sell 10,152 @ $41.42 $420,528 14,673 12/20/2023 12/21/2023
Sell 13,808 @ $41.42 $571,972 16,913 12/20/2023 12/21/2023
Tregoning Kathleen

See Remarks

Sell 6,288 @ $41.42 $260,469 7,516 12/20/2023 12/21/2023
Sanchez Ramiro

Chief Medical Officer

Sell 7,500 @ $41.39 $310,393 0 12/15/2023 12/19/2023
Sanchez Ramiro

Chief Medical Officer

Sell 10,000 @ $41.37 $413,700 0 12/07/2023 12/11/2023
Akamine Scott

Chief Legal Officer

Sell 10,000 @ $41.37 $413,700 513 12/07/2023 12/07/2023
Akamine Scott

Chief Legal Officer

Sell 7,500 @ $35.00 $262,500 513 12/05/2023 12/07/2023

Cerevel Therapeutics Holdings, Inc. Frequently Asked Questions

  • Who is on Cerevel Therapeutics Holdings, Inc.'s Insider Roster?

    The list of insiders at Cerevel Therapeutics Holdings, Inc. includes Akamine Scott, Sanchez Ramiro, Tregoning Kathleen, ALTSCHULLER Susan, DiPietro Kenneth, Bodenrader Mark, COLES N ANTHONY, Renger John.

  • How much insider selling is happening at Cerevel Therapeutics Holdings, Inc.?

    Insiders have sold a total of 409,132 Cerevel Therapeutics Holdings, Inc. shares in the last 12 months for a total of 16.95 M sold.

  • Which Cerevel Therapeutics Holdings, Inc. insiders have been selling company stock?

    The following insiders have sold Cerevel Therapeutics Holdings, Inc. shares in the last 12 months: Akamine Scott ($969,145), Sanchez Ramiro ($1.57 M), Tregoning Kathleen ($260,469), ALTSCHULLER Susan ($571,972), DiPietro Kenneth ($590,752), Bodenrader Mark ($326,788), COLES N ANTHONY ($12.58 M), Renger John ($89,777),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.